This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Biocon Limited. Active years: 2020-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Chinnaelasagiri, IN (2020)
- Periyapanichery, IN (2021 - 2023)
Company Filing History:
Years Active: 2020-2023
Title: Innovations by Rajmahendra Shanmughasamy
Introduction
Rajmahendra Shanmughasamy is a notable inventor based in Periyapanichery, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds. With a total of 3 patents to his name, his work continues to impact the industry positively.
Latest Patents
Shanmughasamy's latest patents include the invention of Trisodium sacubitril valsartan and the process for its preparation. This invention provides a novel process for the preparation of crystalline Form B of N-(3-carboxyl-1-oxopropyl)-(4S)-(p-phenylphenylmethyl)-4-amino-2R-methyl butanoic acid ethyl ester sodium salt. Another significant patent is for Amorphous Trisodium Sacubitril Valsartan, which details the preparation of crystalline Form B1 and B2 of the same compound, showcasing his innovative approach to pharmaceutical formulations.
Career Highlights
Rajmahendra Shanmughasamy is currently associated with Biocon Limited, a leading biopharmaceutical company. His work at Biocon has allowed him to focus on developing new therapeutic solutions that address critical health issues. His expertise in the field has been instrumental in advancing the company's research initiatives.
Collaborations
Shanmughasamy has collaborated with several talented individuals, including Palle Venkata Raghavendra Charyulu and Pratik Rameshchandra Patel. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.
Conclusion
Rajmahendra Shanmughasamy's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in medical science and therapeutic development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
